Search

Eric Nilsson

Examiner (ID: 876, Phone: (571)272-5246 , Office: P/2122 )

Most Active Art Unit
2122
Art Unit(s)
2122, 2198, 2151
Total Applications
576
Issued Applications
432
Pending Applications
65
Abandoned Applications
85

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18725683 [patent_doc_number] => 20230339854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => Negative Allosteric Modulation of GluN3-Containing N-Methyl-D-Aspartate Receptors [patent_app_type] => utility [patent_app_number] => 17/796387 [patent_app_country] => US [patent_app_date] => 2021-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36820 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796387 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/796387
Negative Allosteric Modulation of GluN3-Containing N-Methyl-D-Aspartate Receptors Jan 31, 2021 Abandoned
Array ( [id] => 16977530 [patent_doc_number] => 20210221767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => Crystalline Forms of Zuclomiphene Citrate [patent_app_type] => utility [patent_app_number] => 17/154261 [patent_app_country] => US [patent_app_date] => 2021-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6605 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154261 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/154261
Crystalline forms of zuclomiphene citrate Jan 20, 2021 Issued
Array ( [id] => 16946621 [patent_doc_number] => 20210205312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => TREATMENT OF MEMBRANOUS NEPHROPATHY, IGG4-RELATED DISEASE, AND ANTIPHOSPHOLIPID SYNDROME USING BTK INHIBITOR 2-[(3R)-3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-d]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE [patent_app_type] => utility [patent_app_number] => 17/141930 [patent_app_country] => US [patent_app_date] => 2021-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7337 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17141930 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/141930
TREATMENT OF MEMBRANOUS NEPHROPATHY, IGG4-RELATED DISEASE, AND ANTIPHOSPHOLIPID SYNDROME USING BTK INHIBITOR 2-[(3R)-3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-d]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE Jan 4, 2021 Pending
Array ( [id] => 18193096 [patent_doc_number] => 20230046615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => BIOMASS-BASED PESTICIDES AND METHODS OF MAKING THE SAME [patent_app_type] => utility [patent_app_number] => 17/783316 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11226 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783316 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/783316
BIOMASS-BASED PESTICIDES AND METHODS OF MAKING THE SAME Dec 20, 2020 Pending
Array ( [id] => 18176708 [patent_doc_number] => 20230037437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => FORMULATIONS FOR USE IN THE TREATMENT OF DIFFERENT TYPES OF ADDICTIONS AND DEPENDENCE ON ADDICTIVE SUBSTANCES [patent_app_type] => utility [patent_app_number] => 17/787510 [patent_app_country] => US [patent_app_date] => 2020-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11327 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -135 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787510 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/787510
FORMULATIONS FOR USE IN THE TREATMENT OF DIFFERENT TYPES OF ADDICTIONS AND DEPENDENCE ON ADDICTIVE SUBSTANCES Dec 13, 2020 Abandoned
Array ( [id] => 19140433 [patent_doc_number] => 20240139216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => STABLE ORAL CANNABIDIOL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/265509 [patent_app_country] => US [patent_app_date] => 2020-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265509 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/265509
STABLE ORAL CANNABIDIOL COMPOSITIONS Dec 6, 2020 Pending
Array ( [id] => 18139833 [patent_doc_number] => 20230013669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => Antibacterial Treatment Using a Cannabinoid and an Active Agent [patent_app_type] => utility [patent_app_number] => 17/778910 [patent_app_country] => US [patent_app_date] => 2020-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23514 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778910 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/778910
Antibacterial Treatment Using a Cannabinoid and an Active Agent Nov 26, 2020 Abandoned
Array ( [id] => 18140941 [patent_doc_number] => 20230014782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => NEW SOLID STATE FORM OF LURBINECTEDIN [patent_app_type] => utility [patent_app_number] => 17/777985 [patent_app_country] => US [patent_app_date] => 2020-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12178 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -68 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777985 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/777985
NEW SOLID STATE FORM OF LURBINECTEDIN Nov 22, 2020 Abandoned
Array ( [id] => 16837794 [patent_doc_number] => 20210145806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => Methods of Treating Brain Cancer and Related Diagnostic Methods [patent_app_type] => utility [patent_app_number] => 16/952887 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4708 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952887 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/952887
Methods of Treating Brain Cancer and Related Diagnostic Methods Nov 18, 2020 Abandoned
Array ( [id] => 18147511 [patent_doc_number] => 20230021368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE [patent_app_type] => utility [patent_app_number] => 17/782807 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3057 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782807 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/782807
PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE Nov 18, 2020 Abandoned
Array ( [id] => 20622565 [patent_doc_number] => 12590062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-31 [patent_title] => PD-1/PD-L1 inhibitors [patent_app_type] => utility [patent_app_number] => 17/098171 [patent_app_country] => US [patent_app_date] => 2020-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 158049 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098171 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098171
PD-1/PD-L1 inhibitors Nov 12, 2020 Issued
Array ( [id] => 16822584 [patent_doc_number] => 20210137877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => PRODUCTS AND METHODS FOR USING CANNABIDIOL IN COMBINATION WITH MELATONIN TO INDUCE SLEEP [patent_app_type] => utility [patent_app_number] => 17/091091 [patent_app_country] => US [patent_app_date] => 2020-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6832 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091091 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/091091
PRODUCTS AND METHODS FOR USING CANNABIDIOL IN COMBINATION WITH MELATONIN TO INDUCE SLEEP Nov 5, 2020 Abandoned
Array ( [id] => 16655909 [patent_doc_number] => 20210052545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => COMPOSITIONS AND METHODS OF THEIR USE [patent_app_type] => utility [patent_app_number] => 17/085182 [patent_app_country] => US [patent_app_date] => 2020-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22229 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085182 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/085182
COMPOSITIONS AND METHODS OF THEIR USE Oct 29, 2020 Pending
Array ( [id] => 16805968 [patent_doc_number] => 20210128521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => METHODS OF USING CANNABINOID COMPOSITIONS IN SPORTS MEDICINE APPLICATIONS [patent_app_type] => utility [patent_app_number] => 17/082915 [patent_app_country] => US [patent_app_date] => 2020-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11531 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17082915 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/082915
METHODS OF USING CANNABINOID COMPOSITIONS IN SPORTS MEDICINE APPLICATIONS Oct 27, 2020 Abandoned
Array ( [id] => 18091228 [patent_doc_number] => 20220409569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => Cannabinoid Products with High Bioavailability [patent_app_type] => utility [patent_app_number] => 17/772452 [patent_app_country] => US [patent_app_date] => 2020-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6296 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772452 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/772452
Cannabinoid Products with High Bioavailability Oct 26, 2020 Pending
Array ( [id] => 19904089 [patent_doc_number] => 12281085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-22 [patent_title] => Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/077857 [patent_app_country] => US [patent_app_date] => 2020-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11225 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077857 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/077857
Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof Oct 21, 2020 Issued
Array ( [id] => 18003391 [patent_doc_number] => 20220362157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => NEW HYDROCORTISONE HEMISUCCINATE LYOPHILIZATE [patent_app_type] => utility [patent_app_number] => 17/764584 [patent_app_country] => US [patent_app_date] => 2020-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2604 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764584 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/764584
NEW HYDROCORTISONE HEMISUCCINATE LYOPHILIZATE Oct 15, 2020 Pending
Array ( [id] => 16760974 [patent_doc_number] => 20210106555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => PHYTOCANNABINOID FORMULATIONS AND METHODS FOR EXTRACTION [patent_app_type] => utility [patent_app_number] => 17/070047 [patent_app_country] => US [patent_app_date] => 2020-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7746 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17070047 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/070047
PHYTOCANNABINOID FORMULATIONS AND METHODS FOR EXTRACTION Oct 13, 2020 Abandoned
Array ( [id] => 18725702 [patent_doc_number] => 20230339880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => COMPOSITIONS OF AJULEMIC ACID AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/766638 [patent_app_country] => US [patent_app_date] => 2020-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14349 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -53 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766638 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/766638
COMPOSITIONS OF AJULEMIC ACID AND USES THEREOF Oct 8, 2020 Abandoned
Array ( [id] => 17227199 [patent_doc_number] => 20210353755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => REDUCTION OF POST-SURGERY CANCER METASTASIS BY COMBINATION OF CANNABIDIOL AND NR2F6 INHIBITION [patent_app_type] => utility [patent_app_number] => 17/037284 [patent_app_country] => US [patent_app_date] => 2020-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7976 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17037284 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/037284
Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition Sep 28, 2020 Issued
Menu